In a model of Lewis lung carcinoma, COS treatment of tumor-bearing mice similarly resulted in a reduction of CHI3L1 plasma levels, although no effect on tumor growth was observed.115 In combination with immune checkpoint inhibition, however, COS treatment resulted in a synergistic delay of tumor growth. This evidence concerns the gene CHI3L1 and neoplasm.